Buy NeuBase Therapeutics Inc Stock | NBSE Stock Price & Latest News | Public.com
NBSE

NeuBase Therapeutics Inc

$0.00 (0.00%)Today
    Small Market Cap
    View NeuBase Therapeutics Inc (NBSE) stock trends here

    About NBSE

    NeuBase Therapeutics, Inc. is a biotechnology company. It engages in the development of drugs for patients with genetic neurological disorder. The firms pipelines include Huntington’s Disease, NT0100 Program - PATrOL Enabled gamma-PNA for Huntington's Disease, and NT020...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.09
    -0.17
    -0.26
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.22

    Actual EPS
    Q4 2020

    -$0.18

    Stats

    Market Cap$204,44M
    Volume104
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$12.89
    1 Year Low$4.52
    Open$8.79
    High$9.01
    Low$8.29

    Buy any stock with any amount of money.

    Download the App
    Download the app